India, July 22 -- Carlsmed Inc., a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, announced that it has priced its initial public offering of 6.70 million shares of common stock at an initial price to the public of $15.00 per share.
The shares are expected to begin trading on The Nasdaq Global Select Market under the ticker symbol "CARL" on July 23, 2025.
The offering is expected to close on July 24, 2025.
Carlsmed has granted the underwriters a 30-day option to purchase up to an additional 1.005 million shares of common stock at the initial public offering price, less underwriting discounts and commissions.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-15681895098...